[High prevalence of antiHTLV-1 antibodies in the Boni, an ethnic group of African origin isolated in French Guiana since the 18th century] NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[High prevalence of antiHTLV-1 antibodies in the Boni, an ethnic group of African origin isolated in French Guiana since the 18th century]

C R Acad Sci III. 1984;299(9):351-3. Unique Identifier : AIDSLINE MED/85073722
Gessain A; Calender A; Strobel M; Lefait-Robin R; de The G

Abstract: Antibodies to HTLV-1 (ELISA test using disrupted virus) were studied in different ethnic groups in French Guiana, including 135 blood donors from Cayenne, 97 Boni Blacks and 57 Wayana Indians from Maripasoula area, and 57 Hmong from Cacao village. We observed significant differences between Boni Blacks and Wayana Indians, having respectively 10.3% versus 0% of high antibody titers. The Hmong, recent refugees from Kampuchea, exhibited an intermediate level (3.5%) of infection. These results favour an African origin of HTLV-1 and raise, for the Hmong, the question of an infection acquired in Guiana.
Keywords: Adolescence Adult Africa/ETHNOLOGY Africa, Western Antibodies, Viral/*ANALYSIS English Abstract Enzyme-Linked Immunosorbent Assay French Guiana Human HTLV-BLV Viruses/*IMMUNOLOGY Laos/ETHNOLOGY Negroid Race Retroviridae Infections/EPIDEMIOLOGY Support, Non-U.S. Gov't Suriname West Indies/ETHNOLOGY JOURNAL ARTICLE

KWDadolescenceadultafrica/ethnologyafrica,westernantibodies,viral/KWDanalysisenglishabstractenzyme-linkedimmunosorbentassayfrenchguianahumanhtlv-blvviruses/KWDimmunologylaos/ethnologynegroidraceretroviridaeinfections/epidemiologysupport,non-uKWDsKWDgov'tsurinamewestindies/ethnologyjournalarticle
850430
M8540101

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .